Evidence map›Paper›PMID 42006436›Full record

ArticleAmerican journal of preventive cardiology2026

Chat-based digital clinic encourages individuals at high risk of coronary heart disease to contact physician.

Eero Aaltonen, Nina Mars, Sanni Ruotsalainen, Roope Ripatti, Johanna Aro, Marianne Leinikka, Iiro Heikkilä, Kristina Hotakainen, Elisabeth Widén, Samuli Ripatti

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eero AaltonenInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Nina MarsInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Sanni RuotsalainenInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Roope RipattiInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Johanna AroInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Marianne LeinikkaMehiläinen Oy, Helsinki, Finland.
Iiro HeikkiläMehiläinen Oy, Helsinki, Finland.
Kristina HotakainenDepartment of Clinical Chemistry and Haematology, University of Helsinki, Finland.
Elisabeth WidénInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Samuli RipattiInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42006436
PMCPMC13084084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.